01 / Vendor Profile
ADAPTIVE BIOTECHNOLOGIES CORPORATION Federal Contracts and Awards
UEI DMW5BNQ331K9 · CAGE 5SRQ2
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $2.65M in net contract obligations to ADAPTIVE BIOTECHNOLOGIES CORPORATION across 90 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
ADAPTIVE BIOTECHNOLOGIES CORPORATION contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations-$32.6K
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2019 | $418.4K | 17 | 3 | — |
| FY 2020 | $381.5K | 14 | 3 | −8.8% |
| FY 2021 | $184.0K | 12 | 3 | −51.8% |
| FY 2022 | $422.1K | 15 | 3 | +129.4% |
| FY 2023 | $665.2K | 11 | 4 | +57.6% |
| FY 2024 | $611.9K | 10 | 3 | −8.0% |
| FY 2025 | -$32.6K | 11 | 4 | −105.3% |
04 / Federal Customers
Which federal agencies buy from ADAPTIVE BIOTECHNOLOGIES CORPORATION?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $1.46M | 62 | 55.2% | |
| 97DH | $507.0K | 14 | 19.1% | |
| 3600 | $286.2K | 7 | 10.8% | |
| 7524 | $216.8K | 3 | 8.2% | |
| 2100 | $176.8K | 4 | 6.7% |
05 / Contracting Offices
Which contracting offices buy from ADAPTIVE BIOTECHNOLOGIES CORPORATION?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $1.02M | 40 | 38.3% | |
| HT0014 | DEFENSE HEALTH AGENCY (DHA) | $430.8K | 13 | 16.3% | |
| 36C241 | VETERANS AFFAIRS, DEPARTMENT OF | $286.2K | 7 | 10.8% | |
| 75N900 | NATIONAL INSTITUTES OF HEALTH | $259.2K | 3 | 9.8% | |
| 75F401 | FOOD AND DRUG ADMINISTRATION | $216.8K | 3 | 8.2% | |
| W81K00 | DEPT OF THE ARMY | $117.0K | 3 | 4.4% | |
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $82.5K | 5 | 3.1% | |
| HT9425 | DEFENSE HEALTH AGENCY (DHA) | $76.2K | 1 | 2.9% | |
| 75N910 | NATIONAL INSTITUTES OF HEALTH | $66.7K | 12 | 2.5% | |
| W81XWH | DEPT OF THE ARMY | $59.8K | 1 | 2.3% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 541380 | TESTING LABORATORIES | $1.22M | 36 | 1 | 45.9% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $635.3K | 26 | 4 | 24.0% |
| 621511 | MEDICAL LABORATORIES | $530.2K | 17 | 3 | 20.0% |
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | $126.2K | 1 | 1 | 4.8% |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $76.2K | 1 | 1 | 2.9% |
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | $61.7K | 2 | 1 | 2.3% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $7.7K | 4 | 1 | 0.3% |
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | -$3.3K | 3 | 1 | -0.1% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| Q301 | MEDICAL- LABORATORY TESTING | $2.19M | 74 | 4 | 82.6% |
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | $260.3K | 5 | 2 | 9.8% |
| AC11 | NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; BASIC RESEARCH | $76.2K | 1 | 1 | 2.9% |
| 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $59.8K | 1 | 1 | 2.3% |
| V119 | TRANSPORTATION/TRAVEL/RELOCATION- TRANSPORTATION: OTHER | $42.0K | 2 | 1 | 1.6% |
| 6505 | DRUGS AND BIOLOGICALS | $15.7K | 4 | 1 | 0.6% |
| 6810 | CHEMICALS | $14.3K | 2 | 1 | 0.5% |
| AN47 | R&D- MEDICAL: HEALTH SERVICES (COMMERCIALIZED) | -$6.4K | 1 | 1 | -0.2% |
08 / Competition Pattern
How was ADAPTIVE BIOTECHNOLOGIES CORPORATION’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for ADAPTIVE BIOTECHNOLOGIES CORPORATION?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| W81K0025CA004 | Aug 12, 2025 | $0 | DEPT OF THE ARMY W40M MRC0 WEST | 621511 | Q301 |
10 / Interpreting the Profile
How should you evaluate ADAPTIVE BIOTECHNOLOGIES CORPORATION as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.